Navigation Links
Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
Date:12/7/2007

generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 30 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase III clinical trials. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Medarex Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed herein may constitute forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with product development, unforeseen safety issues resulting from the administration of antibody products in humans, uncertainties concerning Centocor's activities under its agreement with Medarex, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2006 and its quarterly reports on Form 10-Q. There can be no assurance that future milestone payments will be paid, whether the product develo
'/>"/>

SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
2. Medarex to Present at the JPMorgan Small/Mid Cap Conference
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. DaVita Receives Civil Complaint
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
8. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
9. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
10. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions ... hired Robert Trenschel, DO, as chief executive officer. A veteran physician executive with 20 ... duties at Yuma Regional Medical Center on July 13. , “Dr. Trenschel brings an ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... July 02, 2015 ... ... and the overall status of the Gelatin Capsule manufacturers. The report is a ... industry. , The report depicts the global and Chinese market for the Gelatin ...
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved ... with their launch an intention to partner with companies that share a similar ... planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are ...
(Date:7/2/2015)... AL (PRWEB) , ... July 02, 2015 , ... Every year, DUI arrests and fatalities ... July may be the deadliest day of the year when it comes to being on ... “The National Highway Traffic Safety Association reports that 40% of all highway deaths between 2007 ...
Breaking Medicine News(10 mins):Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... , FRIDAY, Sept. 2 (HealthDay News) -- Climate ... departments in the next decade. The prediction was ... regional and atmospheric models. They linked N.Y. State Department ... on asthma-related emergency department visits by children in 14 ...
... to predict which heart transplant patients are at greatest risk ... could help medical teams figure out who would benefit most ... are a limited resource," says John V. Conte, M.D., a ... Medicine and the senior author of the study. "Now, we ...
... News) -- Researchers using scanning technology say they discovered ... autism compared to those of kids without autism. ... children with 92 percent accuracy," based on the volume ... Lucina Uddin, first author of a new study and ...
... (HealthDay News) -- A rapid rise in hookah use in California ... water pipe used for smoking tobacco. An analysis of state data ... more than 40 percent between 2005 and 2008. In 2008, ... higher (24.5 percent of men, 10 percent of women) than it ...
... (HealthDay News) -- Traffic safety should be among a child,s first ... in the United States, more than 25,000 pedestrians aged 5 to ... and Prevention. "Kids who are struck by cars are among ... Because of their height, when a car hits a child, the ...
... Ian Roberts, Head of the World Health Organisation Collaborating Centre ... Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously ... VIIa (the drug presented in the programme) was shown to ... clotting but it has never been shown to save lives. ...
Cached Medicine News:Health News:Researchers develop new way to predict heart transplant survival 2Health News:Brain Scans Show Distinct Traits in Kids With Autism: Study 2Health News:Hookah Use Growing Among Young Adults in California 2Health News:Traffic Safety Should Be Among First Lessons in New School Year 2Health News:Trauma experts criticize BBC's Holby City for 'peddling dangerous drugs' 2
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... 2015  Konica Minolta, Inc. (Konica Minolta) ( ... acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer ... through its Brazilian healthcare sales company, Konica Minolta Healthcare ... Brazil market investment and growth ... 200 million, significant healthcare technical advancements and efficiencies are ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... The quanTtest human protein standards are available ... 100 and 200 mg/dL and are packaged ... liquid, ready-to-use, requiring no reconstitution or dilution ... using purified human albumin and human globulin ...
... binding method provides a simple, ready-to-use ... with greater linearity, using microliter samples ... in manual or automated systems. Assay ... 2, 3, 4 & 5), reagents, ...
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
The Clearblue Easy Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the 2 best ...
Medicine Products: